Sidam sponsors of the Meet in Italy for Life Sciences 2018, the main national matchmaking and updating event in the field of Life Sciences, which will be held in Bologna from 10 to 12 October. During the workshop of October 10, at 11.30 a.m., Sidam will talk about the technical-scientific experience developed with the collaboration of Luigi Dall'Oglio (head of the endoscopic digestive surgical department of Bambino Gesù Hospital) and his team for the study and creation of the dynamic stent, the new device for the dynamic conservative treatment of benign esophageal stenosis.
Also during 2019 Sidam will be present at in the European Congress of Radiology to be held in Vienna from 27 February to 3 March 2019, the most important medical meeting in Europe and the second largest radiological meeting in the world (https://www.myesr.org/congress) and at the International Symposium on Intensive Care and Emergency Medicine to be held in Brussels from 19 to 22 March 2019, one of the largest in its field that offers its visitors an updated overview of the latest developments in research, treatment and management of critical ill (https://www.intensive.org/1/main.asp).
The company has won the 'Imprese X Innovazione - Andrea Pininfarina Award’, assigned by Confindustria for having successfully invested in research and innovation.
This is the first innovation award in Europe to have adopted the parameters of the European Foundation for Quality Management (EFQM) and participates, for the Industry and Services category, to the Prize of Prizes, an award set up by the President of the Council of Ministers on a mandate by the President of the Italian Republic.
We acquired a 75% stake in BTC Medical Europe, leader company in the postoperative blood recovery and oncology sectors and based in Valeggio sul Mincio (VR) and in Nonantola (MO).
The goal is to establish an entirely Italian biomedical centre and to enhance our portfolio of products and markets.
Another important milestone reached by Sidam: Mirandola's production site obtained from FDA (Food and Drug Administration) the Registration Number, which qualifies the company as a production workshop authorized to produce for the United States of America. This certification ensures, also for the North American market, the safety and efficacy of biomedical devices produced by the company, already recognized by the various awarding bodies responsible for Europe, South America and Asia. This recognition will allow Sidam to significantly expand its international business opportunities in the biomedical sector.
Sidam obtains from Confidustria (the main association representing manufacturing and service companies in Italy) the certification of the quality label for the activation of collaborations with schools in the field of the alternation paths between school and work.